RocketTickers

Aldeyra Therapeutics Announces Positive Top-Line Data from Phase

Long
NASDAQ:ALDX   Aldeyra Therapeutics, Inc.
ALDX: Aldeyra Therapeutics, Inc.
2022-01-11 08:00:00
Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.